Anne‐Eva van der Wijk

Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase

Wilco Keulen, Nicole Back, Anne‐Eva van der Wijk et al. · Journal of Virology · 1997 · 143 citations · Full text

Predictors for Non- and Slow Progression in Human Immunodeficiency Virus (HIV) Type 1 Infection: Low Viral RNA Copy Numbers in Serum and Maintenance of High HIV-1 p24-Specific but Not V3-Specific Antibody Levels

Els J. M. Hogervorst, Suzanne Jurriaans, F de Wolf et al. · The Journal of Infectious Diseases · 1995 · 143 citations

Plasmalemma Vesicle–Associated Protein Has a Key Role in Blood-Retinal Barrier Loss

Joanna Wisniewska‐Kruk, Anne‐Eva van der Wijk, Henk A. van Veen et al. · American Journal Of Pathology · 2016 · 72 citations · Full text

Ocular Disease, Key Role, Retina +11

TNFα-Induced Disruption of the Blood–Retinal Barrier In Vitro Is Regulated by Intracellular 3′,5′-Cyclic Adenosine Monophosphate Levels

Anne‐Eva van der Wijk, Ilse M. C. Vogels, Cornelis J.F. Van Noorden et al. · Investigative Ophthalmology & Visual Science · 2017 · 43 citations · Full text

Immunological Adaptations to Pregnancy in Women with Type 1 Diabetes

Bart Groen, Anne‐Eva van der Wijk, Paul P. van den Berg et al. · Scientific Reports · 2015 · 42 citations · Full text